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Abstract: 
 
Extensive fractionation of an extract from the grain-based culture of the endophytic 
fungus Preussia minimoides led to the isolation of two new polyketides with novel skeletons, 
minimoidiones A (1) and B (2), along with the known compounds preussochromone C (3), 
corymbiferone (4), and 5-hydroxy-2,7-dimethoxy-8-methylnaphthoquinone (5). The structures 
of 1 and 2 were elucidated using 1D and 2D NMR data analysis, along with DFT calculations 
of 1H NMR chemical shifts. The absolute configuration of 1 was established by a single-crystal 
X-ray diffraction analysis and TDDFT-ECD calculations. Compounds 1–4 significantly inhibited 
yeast α-glucosidase. 
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Article: 
 
The genus Preussia (Sporormiaceae) comprises species isolated from soil, wood, and plant 
debris. Sporormiella Ellis & Everh. is a similar genus, defined originally to include exclusively 
coprophilous species. Recent studies have demonstrated no difference between the two genera 
with respect to their habitat and other diagnostic morphological features. Thus, some authors 
consider it more appropriate to treat them as synonyms.(1, 2) Preussia minimoides (S.I. Ahmed 
& Cain) Valldos. & Guarro (Sporormiaceae) [Syn: Sporormiella minimoides S.I. Ahmed & 
Cain] is a prolific producer of many interesting polyketides and depsipeptides.(3) Some of these 
metabolites possess interesting biological activities, including cytotoxicity (brocaenol 
A),(4) antibacterial and antifungal activities (sporminarins A and B),(5) and calmodulin 
inhibitory effects (corymbiferone C, corymbiferan lactone E, and 5-hydroxy-2,7-dimethoxy-8-
methylnaphthoquinone).(6) 
 
The search for new α-glucosidase inhibitors and other antidiabetic drugs from natural sources has 
increased notably in recent years, considering that type II diabetes mellitus is one of the most 
challenging health problems of the 21st century. Therefore, as part of an effort to discover new 
α-glucosidases inhibitors useful for the development of antidiabetic drugs, we now report the 
isolation and structure elucidation of two new polyketides with novel skeletons, namely, 
minimoidiones A (1) and B (2), from an endophytic isolate of the fungus P. minimoides obtained 
from Hintonia latiflora (Sessé et Mociño ex DC.) Bullock (Rubiaceae).(6) 
 
 
 
Results and Discussion 
 
The defatted extract from moist rice cultures of P. minimoides inhibited the activity of yeast α-
glucosidase (αGHY) with an IC50 of 38 μg/mL. Extensive fractionation of this extract yielded 
two novel polyketides, the benzo[de]anthracenedione 1 and the 
spiro[naphthalenephenalene]dione 2, which were given the trivial names minimoidiones A and 
B, respectively. In addition, the known compounds preussochromone C (3),(7) corymbiferone 
(4),(8) and 5-hydroxy-2,7-dimethoxy-8-methylnaphthoquinone (5)(6) were isolated. 
Compound 3 was isolated for the first time from P. minimoides, and its NMR data were identical 
to those previously reported. Compounds 4 and 5 were previously obtained from the same isolate 
and were characterized by comparison with authentic samples.(6) 
 
Minimoidione A (1) was isolated as yellow crystals. Its molecular formula, C21H20O7, 
established from HRESIMS data, indicated a structure with 12 degrees of unsaturation. The IR 
(1651 cm–1) and UV (maxima at 205, 221, 260, and 301 nm) spectra revealed absorptions 
indicative of conjugated ketone and aromatic moieties. Analysis of the 1H and 13C NMR data 
indicated the presence of 21 carbon atoms consisting of three methoxy groups, one additional 
methyl, six methines (four in the aromatic-vinylic region and two aliphatic), 11 nonprotonated 
carbons (two conjugated ketones, eight aromatic or olefinic, and one aliphatic), and two hydroxy 
groups (Table 1). On the basis of the 1D and 2D NMR data (Figures S4–S7), two partial 
substructures of 1 (a and b; Figure 1) were elucidated. Rings A and B of substructure a were 
assigned considering the HMBC correlations from H-2 to C-1/C-3/C-3a and from H-5 to C-3a/C-
4/C-6/C-6a; the NOESY cross-peaks between H-2 and 1-OCH3 and from H-5 to 6-OCH3; and 
the presence of a phenolic hydroxy group at δH 13.21 (3-OH), which was chelated with the 
conjugated ketone group at δC 190.4 (C-4). On the other hand, diagnostic chemical shifts for the 
presence of a second α,β unsaturated ketone system and the HMBC correlations from H-10 to C-
8/C-9/C-11/C-11a, from H-8 to C-7/C-7a/C-9/7a-CH3, and from H-11a to C-10/C-11/C-11b 
assembled ring D of substructure b (Figure 1). Consideration of the molecular formula indicated 
that these partial structures have to be linked to form an additional ring (ring C). HMBC 
correlations from H-11a (δH 4.28) to C-1 (δC 163.4 in ring A)/C-10 (δC 100.4 at ring D)/C-11 
(δC 175.1 at ring D)/C-11b (δC 108.9 at ring A) and from H-7 (δH 6.98, ring C) to C-6a/C-7a/C-
8/C-11a (Figure 1) confirmed this tetracyclic system. Altogether, these correlations resulted in 
the planar structure of compound 1. The NOESY (Figure S6) interactions between 7a-CH3, H-8, 
and H-11a indicated that they had the same relative orientation. An X-ray diffraction analysis 
of 1 with Mo Kα radiation confirmed the proposed structure and the relative configuration at the 
chiral centers. An ORTEP drawing of the crystallographically determined structure of 1 is 
depicted in Figure 2. 
 
 
Figure 1. Partial structures a and b and selected HMBC and key NOESY correlations of 
minimoidione A (1). 
 
 
Figure 2. ORTEP drawing of compound 1. 
 
Table 1. 1H (500 MHz) and 13C (125 MHz) NMR Data for Compound 1 in CDCl3 
position δC, type δH (J in Hz) HMBC NOESY 
1 163.4 C       
2 99.2 CH 6.49, s 1, 3, 3a, 11b 1-OCH3 
3 163.1 C       
3a 106.8 C       
3a1 130.5 C       
4 190.4 C       
5 101.4 CH 5.65, s 3a, 4, 6, 6a 6-OCH3 
6 165.1 C       
6a 125.9 C       
7 138.4 CH 6.98, d (1.5) 3a1, 6, 7a, 8, 11a   
7a 44.1 C       
8 76.6 CH 4.25, s 7, 7a, 7a-CH3, 9 7a-CH3 
9 196.6 C       
10 100.4 CH 5.50, d (2.0) 8, 9, 11, 11a 11-OCH3 
11 175.1 C       
11a 41.4 CH 4.28, t (2.0) 1, 10, 11, 11b 7a-CH3 
11b 108.9 C       
1-OCH3 55.9 CH3 3.90, s 1 2 
6-OCH3 55.8 CH3 3.80, s 6 5 
11-OCH3 56.8 CH3 3.53, s 11 10 
7a-CH3 20.9 CH3 1.28, s 7, 7a, 8, 11a 8, 11a 
3-OH     13.21, s 2, 3, 3a   
8-OH     5.30, s     
 
The absolute configuration at the stereogenic centers of 1 was deduced by comparison of the 
experimental and calculated electronic circular dichroism (ECD) spectra of the two possible 
enantiomers (7aS,8S,11aS and 7aR,8R,11aR), which were calculated using time-dependent 
density functional theory (TDDFT). The calculated spectrum for the 7aS,8S,11aS isomer showed 
good agreement with the experimental data (Figure 3). 
 
 
Figure 3. Comparison of the experimental ECD spectrum of 1 (black) with those calculated at 
the B3LYP/6-31+G(d) level for enantiomers 7aS,8S,11aS (red) and 7aR,8R,11aR (blue). 
 
Minimoidione B (2) was isolated as an optically inactive orange solid that analyzed for 
C26H22O8, which would require 16 double-bond equivalents. The IR spectrum showed 
characteristic absorptions for aromatic ring (1623 and 1461 cm–1), hydroxy group (3437 cm–1), 
and carbonyl groups (1653 cm–1). The 1D and 2D NMR data (Table 2) included signals for four 
methoxy groups, one methylene, six aromatic or olefinic methines, and 16 nonprotonated 
carbons, including two conjugated ketone carbonyls, 14 aromatic, six of which were oxygenated, 
and one aliphatic. Finally, two phenolic chelated hydroxy groups were detected (δH 13.30 and 
13.14). As in compound 1, detailed analysis of the 2D NMR spectra, in particular of the HMBC 
data, led to partial structures c and d indicated in Figure 4. Substructure c (rings A and B), 
identical to substructure a of compound 1, was elucidated on the basis of the HMBC cross-peaks 
from H-8′ to C-6′a/C-7′/C-9, from H-5′ to C-3′/C-4′/C-6′, and from H-2′ to C-1/C-3′/C-4′. 
Furthermore, the NOESY correlations from H-8′ to 9′-OCH3 and H-5′ to 4′-OCH3 and the 
chelated phenolic hydroxy group at δH 13.14 (7′-OH) completed the assembly. On the other 
hand, substructure d (including rings D and E and a methylene functionality) was established 
considering the following HMBC correlations: from H-6 to C-4a/C-5/C-7/C-8, from H-3 to C-
1/C-2/C-4/C-4a, from H-8 to C-1/C-4a/C-7, and from H2-1′ to C-1/C-2/C-8a. The AB system for 
two meta-related protons observed in the 1H NMR between H-6 (δH 6.35, d, J = 2.5 Hz) and H-8 
(δH 6.24, d, J = 2.5 Hz) and the NOESY correlations between H-3 and H-6 with the methoxy 
groups at C-2 and C-7, respectively, further supported substructure d. These partial structures 
were linked to form an additional ring (ring C), based on the unsaturation count and the HMBC 
correlations from H-1a′ and H-1b′ (δH 3.39 and 3.19, dd, J = 18 Hz) to C-2′/C-3a′/C-9′/C-10′ 
(Figure 4). In addition, the correlations from H-1a′ and H-1b′ to C-1, from H-2′ to C-1, from H-3 
to C-1, and from H-8 to C-1 indicated that ring C was linked to ring D in a spiro fashion (Figure 
4). The only asymmetric center of compound 2 was located at C-1, but the lack of optical activity 
and molecular symmetry indicated that the compound was a racemic mixture. On the basis of the 
above considerations, the structure of compound 2 was fully assembled. 
 
 
Figure 4. Partial structures c and d and selected HMBC and key NOESY correlations of 
minimoidione B (2). 
 
Table 2. 1H (500 MHz) and 13C (125 MHz) NMR Data for Compound 2 in CDCl3 
position δC, type δH (J in Hz) HMBC NOESY 
1 44.6 C       
2 177.8 C       
3 100.6 CH 5.70, s 1, 2, 4, 4a 2-OCH3 
4 189.7 C       
4a 106.7 C       
5 164.6 C       
6 99.9 CH 6.35,d (2.5) 4a, 5, 7, 8 7-OCH3 
7 164.7 C       
8 106.4 CH 6.24, d (2.5) 1, 4a, 6, 7 7-OCH3, 1′ 
8a 129.2 C       
2-OCH3 56.7 OCH3 3.80, s 2 3 
7-OCH3 55.4 OCH3 3.67, s 7 6, 8 
1′ 33.1 CH2 3.39, d (18) 1, 2, 2′, 3a′, 8a, 9′, 10′ 8 
      3.19, d (18)     
2′ 135.0 CH 6.67, s 1, 2, 3′, 4′ 4′-OCH3 
3′ 126.5 C       
3a′ 147.0 C       
4′ 164.8 C       
5′ 102.1 CH 5.75, s 3′, 4′,6′, 6a′ 4′-OCH3 
6′ 190.1 C       
6a′ 106.7 C       
7′ 162.4 C       
8′ 99.3 CH 6.45, s 7′, 6a′, 10′ 9′-OCH3 
9′ 161.6 C       
10′ 109.8 C       
4′-OCH3 56.0 OCH3 3.84, s 4′ 2′, 5′ 
9′-OCH3 55.7 OCH3 3.79, s 9′ 8′ 
OH-5     13.30, s 5, 6   
OH-7′     13.14, s     
 
All attempts to obtain suitable crystals of 2 for X-ray analysis failed. Therefore, in order to 
provide further evidence for our structural assignment of 2, 1H NMR chemical shifts were 
calculated and compared with the experimental data according to the protocol of Willoughby and 
collaborators.(9) Basically, this protocol involves a conformational search using molecular 
mechanics, geometry optimization using DFT, and chemical shift calculations using the GIAO 
method with the B3LYP/6-311+G(2d,p) level of theory. The computed 1H NMR chemical shifts 
of compound 2 (Tables S5 and S7) were all within 0.28 ppm of the corresponding experimental 
values. As can be seen in Tables S5 and S8, the matched mean absolute error was <0.17 ppm.(9) 
 
 
Figure 5. Model of binding for compounds 1 (yellow sticks) and the two stereoisomers 
of 2, R (cyan sticks) and S (green sticks), with αGHY (blue cartoon, pdb 3A4A). The insets show 
details of the binding mode for 1 (A and E), 2R (B and F), and 2S (C and G). 
 
Compounds 1–4 inhibited yeast α-glucosidase (αGHY), with IC50’s ranging from 2.9 to 155 μM 
(Table S9). Among them, compound 2 showed the strongest effect (IC50 = 2.9 μM). In all cases, 
the activity was compared to that of an acarbose standard (IC50 = 877 μM). In order to envisage 
the putative binding mode of compounds 1 and 2 with αGHY, docking analyses were carried out 
using the crystallized structure of αGHY (pdb code 3A4A).(10, 11) The docking protocol was 
validated reproducing the binding mode of acarbose at the catalytic domain (Figure S23).(12, 
13) Next, minimiodione A (1) and the R and S enantiomers of 2 were docked into the validated 
α-glucosidase model. The results predicted that the R enantiomer of compound 2 binds in a site 
different from the catalytic domain [binding energy (ΔG) = −7.7 kcal/mol]. This site was 
composed mainly by hydrophobic interactions including Pro488, Asn493, Phe494, Glu497, 
Phe563, Gly564, Tyr566, and Lys569 and hydrogen bonds between Lys373 and Lys568 (Figure 
5C and F). On the other hand, docking of compound 1 and the S stereoisomer of 2 suggested that 
they bind to the catalytic site of αGHY with higher affinities (ΔG = −8.5 and −10.4 kcal/mol, 
respectively). The interactions in this site included hydrophobic contacts with Tyr158, Asp242, 
Phe314, Arg315, Tyr316, Glu411, and Asn415 and hydrophilic interactions with Ser240, 
His280, and Gln353 (Figure 5A, E, C, and G). 
 
Experimental Section 
 
General Experimental Procedures 
 
Melting points were determined on a Fisher-Johns apparatus and are uncorrected. IR, UV, and 
ECD spectra were obtained on a PerkinElmer 400 FT-IR, a Shimadzu U160, and a JASCO 
model J720 spectrophotometer, respectively. Optical rotations were recorded at the sodium D-
line wavelength using a PerkinElmer model 343 polarimeter at 20 °C. 1D and 2D NMR spectra 
were recorded on a 400 MHz Bruker Avance III (operating at 400 MHz for 1H and 100 MHz 
for 13C), a Varian Inova 300 MHz (operating at 300 MHz for 1H and 75 MHz for 13C), or a 
Varian Unity Inova 500 MHz (operating at 500 MHz for 1H and 125 MHz for 13C) spectrometer; 
spectra were recorded using CDCl3 and tetramethylsilane as an internal standard. HRESIMS 
spectra were obtained using a Thermo LTQ Orbitrap XL mass spectrometer. 
 
ESIMS analyses were performed on an SQD2 single-quadrupole mass spectrometer with an 
electrospray ion source. Data acquisition and processing was accomplished with the MassLynx 
software version 4.1 (Waters). HPLC was carried out on a Waters system equipped with a 2535 
pump and a 2998 photodiode array detector; data acquisition and management of 
chromatographic output were performed with the Empower 3 software (Waters). Reagent-grade 
dichloromethane, n-hexane, and methanol and HPLC-grade acetonitrile and methanol (J.T. 
Baker) were regularly used in the extraction and isolation procedures. Silica gel 60 (70–230 
mesh, Merck) and Sephadex LH-20 (General Electric) were used for column chromatography 
(CC). TLC analyses were performed on precoated silica gel 60 F254 plates (Merck) using 
different mobile phases, and visualization of plates was carried out using a 10% 
Ce(SO4)2 solution in H2SO4 and heating. 
 
Isolation and Identification of P. minimoides 
 
The endophytic fungus P. minimoides was isolated from selected adult and healthy leaves of H. 
latiflora, collected by Sol Cristians in Huetamo (18°31.709′ N, 101°4.692′ W; 221 masl), State 
of Michoacan, Mexico, on July 2010. Identification of the plant was secured by the collector; a 
voucher specimen (131 336) was deposited at the Herbario de la Facultad de Ciencias (FCME), 
Mexico City, Mexico. The fungus was isolated as previously described.(6) The pure fungal strain 
was obtained after serial transfers on PDA plates and deposited into the Herbario Nacional de 
México (MEXU, voucher number 26355). The fungus was identified based on morphological 
characteristics, such as ascospore morphology.(6) Sequence data [internal transcribed spacer 
(ITS) and 28S rRNA] were deposited in GenBank as accessions KF557658 and KF557659, 
respectively. Data available at GenBank aligning with MEXU 26355 suggested this fungus is P. 
minimoides. 
 
Fermentation, Extraction, and Isolation 
 
Erlenmeyer flasks with 50 mL of potato-dextrose broth (Difco) sterilized by autoclaving at 121 
°C for 15 min were individually inoculated with 1 cm3 agar taken from a stock culture of P. 
minimoides on PDA plates. Cultures grown for 1 week were used to inoculate eight 2.8 L 
Fernbach flasks containing solid rice medium (200 g of white rice and 400 mL of H2O). P. 
minimoides was cultured at room temperature for 45 days in static conditions with a 12/12 h 
daily light–dark period. After incubation, the solid medium was extracted exhaustively with a 
mixture of CH2Cl2–MeOH (8:2) via maceration. The extract was dried over Na2SO4 (anhydrous) 
and concentrated in vacuo to yield 7.3 g of a brownish oily residue. The extract was reconstituted 
with MeOH–MeCN (1:1) and partitioned with n-hexane to yield two primary fractions. The 
MeOH–MeCN fraction (5.4 g) inhibited the activity of the yeast α-glucosidase with an IC50 of 38 
μg/mL, and it was further fractionated via silica gel column chromatography, eluting with a 
gradient of n-hexane–CH2Cl2 (100:0 → 0:100) and CH2Cl2–MeOH (100:0 → 80:20) to afford 
nine secondary fractions (F1–F9). Fraction F6 (184.8 mg) was subjected to Sephadex LH-20 CC 
eluting with CH2Cl2–MeOH (8:2) to afford six fractions (F6I–F6VI). Fraction F6IV (71.5 mg) 
was further purified by reversed-phase HPLC (Gemini C18, 250 × 21.24 mm, 5 μm, 
Phenomenex) using as mobile phase 30:70 MeCN–H2O (acidified with 0.1% formic acid) and 
increasing linearly to 50% MeCN over 30 min and finally to 100% MeCN for 5 min, at a flow 
rate of 21.24 mL/min. This process yielded 5.6 mg of 1 as yellow needles. Fraction F4 (184.8 
mg) was first washed with n-hexane (80 mL); the resulting residue (107.3 mg) was further 
purified by reversed-phase HPLC (Gemini C18, 250 × 21.24 mm, 5 μm, Phenomenex) using as 
mobile phase 60:40 MeCN–H2O (acidified with 0.1% formic acid) and increasing linearly to 
MeCN over 15 min, at a flow rate of 21.24 mL/min; this procedure afforded 11.6 mg of 2 as an 
orange solid and 20.3 mg of 4 as a yellow powder. 
 
Fraction F9 (425.9 mg) was purified by silica gel chromatography with a gradient of Hex–AcOEt 
(100:0 → 0:100) and AcOEt–MeOH (100:0 → 70:30) to afford seven fractions (F9I– F9VII). 
Fraction F9IV (48.8 g) was further purified by reversed-phase CC (Gemini C18, 250 × 21.24 mm, 
5 μm, Phenomenex) using as mobile phase 70:30 MeCN–H2O (acidified with 0.1% formic acid) 
and increasing linearly to 50% MeCN over 30 min, at a flow rate of 21.24 mL/min, to obtain 3.2 
mg of 3 as a yellow, amorphous solid. Fraction F2 (68.2 mg) was washed with n-hexane (30 mL) 
and then was subjected to Sephadex LH-20 chromatography eluting with CH2Cl2–MeOH (8:2) to 
afford five fractions (F2I–F2V). From fraction F2IV spontaneously precipitated 16.3 mg of 5 as 
an orange powder. 
 
Minimoidione A (1): 
 
(C21H20O7) yellow needles; mp 230–232 °C; [α]20D +27.17 (1 mg/mL, CHCl3); UV 
(MeOH, c 1.8) λmax (log ε) 221 (−3.8), 243 (1.8), 258 (−0.1), 268 (0.3), 316 (−0.6) nm; IR 
(FTIR) νmax 3640, 3119, 1670, 1616, 1246 cm–1; 1H and 13C NMR in Table 1; 
HRESIMS m/z 385.1270 [M + H]+, calcd 385.1282. 
 
Minimoidione B (2): 
 
(C26H22O8) orange solid; mp 280–281 °C; [α]20D 0 (1 mg/mL, CHCl3); IR (FTIR) νmax 3065, 
3916, 2956, 1633, 1587, 1572, 1229, 1214 cm–1; 1H and 13C NMR in Table 2; 
HRESIMS m/z 463.1375 [M + H]+, calcd 463.1387. 
 
X-ray Crystal Structure Analysis of Compound 1 
 
Single crystals suitable for X-ray analysis were obtained by recystallization from CHCl3–MeOH 
(8:2). A yellow crystal having approximate dimensions of 0.273 × 0.118 × 0.076 mm was 
mounted on a glass fiber. All measurements were made on a Bruker Smart Apex CCD 
diffractometer equipped with graphite-monochromated Mo Kα radiation (λ = 0.710 73 Å) at 150 
K. The structure was solved by the SHELXS-2013 method and refined using full-matrix least-
squares on F2. Suitable crystals of 1 were obtained by evaporation of CH2Cl2–MeOH (8:2). 
Crystallographic data for 1 have been deposited with the Cambridge Crystallographic Data 
Centre (CCDC) with the accession no. 1475816. These data are available, free of charge, from 
the CCDC via http://www.ccdc.cam.ac.uk/data_request/cif. 
 
Crystal data for 1: 
 
C21H20O7, MW 384.37, monoclinic, space group P21/n, with unit cell parameters a = 9.1302(13) 
Å, b = 15.476(2) Å, c = 13.420(2) Å, α = 90°, β = 109.085(3)°, γ = 90°, Z = 4, T = 150(2) K, 
volume 1792.0(4) Å3, F(000) 808, density(calcd) 1.425 Mg/m3. Intensity data were collected in 
the range of 2.382–25.193° using a ω scan; 10 832 reflections collected, 3193 independent 
reflections [R(int) = 0.1193] were considered, observed, and used in the calculations. The 
final R1 values were 0.0568 [I > 2σ(I)]. The final wR2(F2) values were 0.1138 [I > 2σ(I)], with a 
data–restraints–parameters ratio of 3193/2/263. The final R1 values were 0.1021 (all data). The 
final wR2(F2) values were 0.1404 (all data). 
 
Computational Section 
 
Minimum energy structures for the different stereoisomers were built with Spartan’08 software 
(Wavefunction Inc.). Conformational analysis was performed with the Monte Carlo search 
protocol as implemented in the same software under the MMFF94 molecular mechanics force 
field. The resulting conformers were minimized using the DFT method at the B3LYP/6-
311+G(2d,p) level of theory for NMR chemical shift prediction. NMR shielding tensors were 
computed with the gauge-independent atomic orbital (GIAO) method and the polarizable 
continuum model using the integral equation formalism variant (IEFPCM) as the SCRF 
method.(9) The TDDFT method at the B3LYP/6-31+G(d) level of theory was employed for ECD 
calculations using the same DFT-minimized conformers. The self-consistent reaction field with 
conductor-like continuum solvent model was used to perform the ECD calculations of the major 
conformers of both 1 enantiomers in MeOH. The calculated excitation energy (nm) and rotatory 
strength (R) in dipole velocity (Rvel) and dipole length (Rlen) forms were simulated into an ECD 
curve. All calculations were performed employing the Gaussian’09 program package (Gaussian 
Inc.). 
 
The minimized structures for docking simulations were prepared using Autodock Tools package 
v1.5.4 (ADT, http://mgltools.scripps.edu/).(14) For metabolites, addition of Gasteiger charges 
and number of torsions were set, and nonpolar hydrogens were merged. The crystallographic 
structure of α-glucosidase from yeast was obtained from the Protein Data Bank (RCSB; pdb 
code 3A4A). For the receptor all hydrogens (polar and nonpolar) and Kollman charges were 
added, and solvation parameters were assigned by default. 
 
Molecular docking studies were achieved with AutoDock Vina v1.1.2.(15) First, a blind docking 
was performed in order to establish the common site of interaction of the metabolites with the α-
glucosidase. The search space for this preliminary docking was defined as a box size of 54 × 68 
× 68 Å in the x, y, and z dimensions, with a grid spacing of 1.0 Å and the macromolecule set as 
the center of the box. The default parameters of exhaustiveness and number of modes were not 
altered. Next, a refined docking was performed with a smaller box of searching space (30 × 25 × 
25 Å and 1.0 Å of grid spacing), setting as the center of the grid box the lower state pose 
obtained from the blind docking. The conformational states from the docking simulations were 
analyzed using the AutoDockTools program, which also identified the H-bonds and van der 
Waals interactions between the catalytic site of α-glucosidase and the ligand. The predicted 
docked complexes (protein–ligand) were those conformations showing the lowest binding 
energy. The estimated inhibition constant (Ki) was calculated from the docking energy displayed 
by AutoDock Vina following the equation Ki = exp(ΔG × 1000/RT), where ΔG is the docking 
energy, R is the universal constant of an ideal gas (1.987 19 cal K–1 mol–1), and T is the 
temperature (298.15 K). Preparation of the figures was accomplished with the PyMOL 
visualization tool (PyMOL Molecular Graphics System, version 1.7.4, Schrödinger, 
LLC)(16) and LigPlot+.(17) 
 
Assay for α-Glucosidase Inhibitors 
 
The fungal extract, fractions, compounds, and acarbose (positive control) were dissolved in 
MeOH. Aliquots of 0–40 μL of testing materials (triplicated) were incubated for 10 min with 20 
μL of enzyme stock solution (0.4 units/mL in phosphate buffer solution 100 mM, pH 7). After 
incubation, 10 μL of substrate (pNPG 5 mM) was added and further incubated for 30 min at 37 
°C,(18) and the absorbances were determined. For the extract and fractions, the inhibitory 
activity was determined as a percentage in comparison to the blank (MeOH) according to the 
following equation: where % αGHY is the percentage of 
inhibition, A415t is the corrected absorbance of the extract, fractions, or compound under testing 
(A415 end – A415 initial), and A415c is the absorbance of the blank (A415 end blank – A415 initial blank). The 
IC50 was calculated by regression analysis, using the following equation:
where A100 is the maximum inhibition, I is the inhibitor concentration, IC50 is the concentration 
required to inhibit activity of the enzyme by 50%, and s is the cooperative degree.(19) 
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Figure S17. 1H NMR spectrum of corymbiferone (4) in CDCl3. 
 
 
Figure S18. 13C NMR spectrum of corymbiferone (4) in CDCl3. 
 
 
 
 
Figure S19. 1H NMR spectrum of 5-hydroxy-2,7-dimethoxy-8-methylnaphthoquinone (5) in CDCl3.  
 
Figure S20. 13C-NMR spectrum of 5-hydroxy-2,7-dimethoxy-8-methylnaphthoquinone (5) in CDCl3.
Preussochromone C (3): yellow powder; mp: 243-245 °C; [α]25D +151 (1 mg/mL, MeOH);
 DC 
(c 0.01 mg/mL, CHCl3) λmax (∆ε) 336 (+2.1), 296 (-0.1), 255 (+6.9); 
1H-RMN (500 MHz, CDCl3) δH 
(ppm): 13.15 (1H, s, OH-1), 6.53 (1H, s, H-2), 5.63 (1H, s, H-7), 4.81 (1H, d, J = 12 Hz, CH2-10a), 
4.21 (1H, d, J = 12 Hz, CH2-10b), 3.97 (3H, s, CH3O-12), 3.88 (3H, s, CH3O-11); 
13C-RMN (175 
MHz, CDCl3) δC (ppm): 189.1 (C-8), 173.1 (C-6), 166.4 (C-1), 165.4 (C-3), 159.5 (C-9), 145.4 (C-4a), 
105.2 (C-8a), 104.7 (C-4), 100.5 (C-7), 100.1 (C-2), 69.5 (C-10), 63.5 (C-5), 56.6 (CH3O-12), 56.3 
(CH3O-11); ESIMS m/z 293 [M+H]
+. 
 Corymbiferone (4): yellow powder; mp: 255-257 °C; UV (MeOH) λmax: 212, 245, 276, 364 
nm; IR (FTIR-ATR) νmax: 3474, 3074, 2949, 1741, 1647, 1588, 1561, 1381 cm
-1; 1H-RMN (700 MHz, 
CDCl3) δH (ppm): 14.56 (1H, s, OH-8), 8.25 (1H, s, H-10), 6.57 (1H, s, H-7), 5.92 (1H, s, H-2), 4.06 
(3H, s, CH3O-6), 3.96 (3H, s, CH3O-3); 
13C-RMN (175 MHz, CDCl3) δC (ppm): 188.5 (C-1), 170.4 (C-
8), 167.5 (C-6), 165.0 (C-3), 156.0 (C-9), 152.1 (C-10), 136.9 (C-4a), 107.9 (C-4), 105.0 (C-8a), 101.3 
(C-2), 99.9 (C-7), 99.6 (C-5), 56.9 (CH3O-6), 56.3 (CH3O-3); ESIMS m/z 275 [M+H]
+. 
 5-Hydroxy-2,7-dimethoxy-8-methylnaphthoquinone (5): orange powder; mp: 165–167 °C; 
UV (MeOH) λmax (log ε): 220 (4.5), 265 (4.1), 297 (4.0) nm; IR (FTIR-ATR) νmax: 3067, 2929, 1678, 
1632, 1600, 1434, 1373, 1237 cm-1; 1H-RMN (500 MHz, CDCl3) δH (ppm): 13.28 (1H, s, OH-5), 6.63 
(1H, s, H-6), 6.02 (1H, s, H-3), 3.90 (3H, s, CH3O-7), 3.88 (3H, s, CH3O-2), 2.52 (3H, s, CH3-8); 
13C-
RMN (125 MHz, CDCl3) δC (ppm): 189.4 (C, C-4), 181.2 (C, C-1), 164.2 (C, C-7), 162.8 (C, C-5), 
161.0 (C, C-2), 128.8 (C, C-8a), 126.8 (C, C-8), 108.4 (C, C-5a), 108.3 (CH, C-3), 104.2 (CH, C-6), 
56.5 (CH3, OCH3-2), 56.2 (CH3, OCH3-7), 12.6 (CH3, C-8); HRESIMS m/z 249.0680 [M+H]
+ (calcd 
for C13H12O5, 248.0684). 
 
 
 
Table S1. Geometry Optimization and 1H NMR Single-Point Calculations at DFT B3LYP/6-311+G(2d,p) Level 
of Theory for Minimoidione A (1). 
Conformer 
Gauss 
Energy 
Energy 
(kcal/mol) 
∆G 
Molar Fraction 
(kcal/mol) 
01 -1338.917 -840183.58306 0.00000 0.499892 
02 -1338.917 -840183.58306 0.00000 0.499892 
04 -1338.91 -840178.58181 5.00125 1.08E-04 
03 -1338.91 -840178.58055 5.00251 1.08E-04 
 
Conformer Calculated chemical shift (δ)  
01 02 03 04 δ01 δ02 δ03 δ04 δcalcd* δexp |δexp-δcalcd| 
25.4184 25.4184 25.3457 25.3457 6.18624696 6.18624696 6.25435638 6.25435638 6.19 6.49 0.3037 
26.234 26.234 25.6745 25.6746 5.42214727 5.42214727 5.94631816 5.94622447 5.42 5.65 0.2277 
24.4064 24.4064 24.5921 24.5919 7.13434514 7.13434514 6.96037099 6.96055837 7.13 6.98 0.1543 
27.491 27.491 27.4635 27.4634 4.24451939 4.24451939 4.27028293 4.27037662 4.24 4.28 0.0355 
30.8896 30.8896 30.9113 30.9113 1.06052089 1.06052089 1.04019112 1.04019112 1.06 1.28 0.2195 
30.8592 30.8591 30.9582 30.9581 1.08900131 1.089095 0.99625258 0.99634626 1.09 1.28 0.1910 
30.3637 30.3637 30.3591 30.359 1.55321342 1.55321342 1.55752295 1.55761664 1.55 1.28 0.2732 
27.481 27.481 27.4467 27.4466 4.25388795 4.25388795 4.28602211 4.2861158 4.25 4.25 0.0039 
26.3332 26.3332 26.2392 26.2392 5.32921117 5.32921117 5.41727562 5.41727562 5.33 5.5 0.1708 
27.9543 27.9543 27.9509 27.9508 3.81047405 3.81047405 3.81365936 3.81375304 3.81 5.30 1.4895 
18.1785 18.1784 18.3402 18.3399 12.9689901 12.9690838 12.8175005 12.8177815 12.97 13.21 0.2410 
28.1613 28.1613 28.2214 28.2217 3.61654488 3.61654488 3.56023984 3.55995878 3.62 3.80 0.1835 
27.802 27.802 27.7555 27.7554 3.9531572 3.9531572 3.996721 3.99681469 3.95 3.80 0.1532 
28.1716 28.1716 28.4389 28.4389 3.60689526 3.60689526 3.35647367 3.35647367 3.61 3.80 0.1932 
28.0393 28.0718 28.0474 28.0478 3.7308413 3.70039348 3.72325276 3.72287802 3.72 3.90 0.1844 
28.0718 27.7726 28.1222 28.122 3.70039348 3.98070077 3.65317594 3.65336331 3.84 3.90 0.0595 
27.7726 28.0393 27.6663 27.6663 3.98070077 3.7308413 4.08028855 4.08028855 3.86 3.90 0.0442 
28.1307 28.5082 28.1098 28.5549 3.64521267 3.29154956 3.66479295 3.24779839 3.47 3.53 0.0616 
28.505 28.1307 28.4957 28.1099 3.2945475 3.64521267 3.30326026 3.66469927 3.47 3.53 0.0601 
28.5082 28.505 28.5549 28.4957 3.29154956 3.2945475 3.24779839 3.30326026 3.29 3.53 0.2370 
*Computed with B3LYP/6-311+G(2d,p)//B3LYP/6-311+G(2d,p). 
 
  
 
Table S2. Comparison of Computed and Experimental 1H NMR Data for 1.  
Position δH Exp δH Calcd*  
2 6.49 6.19 
 
5 5.65 5.42 
7 6.98 7.13 
8 4.25 4.25 
10 5.50 5.33 
11a 4.28 4.24 
1-OCH3 3.90 3.87 
6-OCH3 3.80 3.72 
11-OCH3 3.53 3.41 
7a-CH3 1.28 1.23 
3-OH 13.21 12.97 
MAE 0.158 
 
*Chemical shifts were derived from application of scaling factors (slope = −1.0674, intercept = 32.0216) to the 1H NMR shielding tensors computed at the 
B3LYP/6-311+G(2d,p) level of theory. 
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Table S3. Calculated DFT B3LYP/6-31+G(d) Free Energies, Population and Theoretical Averaged 
Rotatory Strength Values Expressed in R(len) for Conformers of 7aS,8S,11aS Enantiomer of 1. 
 Conformer   
 
1 2 3 4   
  ∆Ga 0 0 4.743 4.741 Weighted 
valuedd λ(nm)
e 
  P(%)b 49.98 49.98 0.02 0.02 
n-statesc 
1 -5.711 -5.711 0.071 1.01 -5.709 415.564 
2 13.707 13.707 40.183 59.118 13.72 352.95 
3 -0.917 -0.917 -26.022 -41.551 -0.929 330.375 
4 -3.205 -3.204 1.58 0.993 -3.203 329.18 
5 2.871 2.871 -0.439 -0.363 2.87 318.324 
6 -31.171 -31.173 -45.596 -1.429 -31.169 300.221 
7 40.434 40.435 52.548 -15.149 40.426 292.981 
8 4.608 4.608 10.126 26.242 4.612 284.751 
9 -2.952 -2.952 -1.86 -2.16 -2.951 280.661 
10 10.116 10.116 -7.219 -2.32 10.11 267.994 
11 -45.18 -45.179 8.044 -4.275 -45.162 262.462 
12 7.836 7.835 -14.377 9.083 7.832 258.211 
13 22.316 22.317 -6.076 -4.665 22.306 256.3 
14 -15.158 -15.158 -29.079 -5.416 -15.159 252.68 
15 72.34 72.338 13.482 3.818 72.316 246.511 
16 26.981 26.983 92.552 -5.54 26.988 232.845 
17 -65.025 -65.027 -27.92 1.21 -65.007 231.851 
18 19.253 19.253 -9.582 77.071 19.259 229.23 
19 33.936 33.935 2.836 -1.8 33.923 226.67 
20 -28.349 -28.339 -7.36 -5.988 -28.336 224.53 
21 -15.015 -15.026 85.198 5.479 -14.999 224.119 
22 -1.86 -1.859 3.204 0.42 -1.858 221.339 
23 33.986 33.986 -18.418 -0.485 33.97 219.809 
24 -23.998 -24 5.157 -10.902 -23.991 216.28 
25 -42.527 -42.523 -83.157 -59.659 -42.535 214.97 
26 -10.63 -10.629 -0.483 -10.505 -10.628 214.539 
27 -2.357 -2.358 -10.299 -12.206 -2.361 211.6 
28 17.316 17.308 1.833 27.959 17.311 209.569 
29 -23.766 -23.758 -8.522 -1.45 -23.755 209.289 
30 -6.661 -6.662 2.304 0.439 -6.658 206.99 
 
aDFT B3LYP/6-31+G(d) Gibbs free energies in kcal mol-1 relative to the absolute G value for the global minimum 
−840032.1537 kcal mol-1. bIn percent from ∆G values at 298 K and 1 atm. cDFT B3LYP/6-31+G(d) Rotatory 
strength values expressed in R(len). dCalculated with the equation ΣiR(len)i × Pi, where R(len)i is the theoretical 
R(len) value calculated for the n = 1-30 excitation state and Pi is the population for the ith conformer. eAveraged 
excitation state. 
 
Table S4. Calculated DFT B3LYP/6-31+G(d) Free Energies, Population and Theoretical Averaged 
Rotatory Strength Values Expressed in R(len) for Conformers of 7aR,8R,11aR  Enantiomer of 1. 
 Conformer   
 
1 2 3 4   
  ∆Ga 0 0 4.743 4.741 Weighted 
valuedd λ(nm)
e 
  P(%)b 49.98 49.98 0.02 0.02 
n-statesc 
1 5.711 5.711 -0.071 -1.010 5.709 415.564 
2 -13.707 -13.707 -40.183 -59.118 -13.720 352.95 
3 0.917 0.917 26.022 41.551 0.929 330.375 
4 3.205 3.204 -1.580 -0.993 3.203 329.18 
5 -2.871 -2.871 0.439 0.363 -2.870 318.324 
6 31.171 31.173 45.596 1.429 31.169 300.221 
7 -40.434 -40.435 -52.548 15.149 -40.426 292.981 
8 -4.608 -4.608 -10.126 -26.242 -4.612 284.751 
9 2.952 2.952 1.860 2.160 2.951 280.661 
10 -10.116 -10.116 7.219 2.320 -10.110 267.994 
11 45.180 45.179 -8.044 4.275 45.162 262.462 
12 -7.836 -7.835 14.377 -9.083 -7.832 258.211 
13 -22.316 -22.317 6.076 4.665 -22.306 256.3 
14 15.158 15.158 29.079 5.416 15.159 252.68 
15 -72.340 -72.338 -13.482 -3.818 -72.316 246.511 
16 -26.981 -26.983 -92.552 5.540 -26.988 232.845 
17 65.025 65.027 27.920 -1.210 65.007 231.851 
18 -19.253 -19.253 9.582 -77.071 -19.259 229.23 
19 -33.936 -33.935 -2.836 1.800 -33.923 226.67 
20 28.349 28.339 7.360 5.988 28.336 224.53 
21 15.015 15.026 -85.198 -5.479 14.999 224.119 
22 1.860 1.859 -3.204 -0.420 1.858 221.339 
23 -33.986 -33.986 18.418 0.485 -33.970 219.809 
24 23.998 24.000 -5.157 10.902 23.991 216.28 
25 42.527 42.523 83.157 59.659 42.535 214.97 
26 10.630 10.629 0.483 10.505 10.628 214.539 
27 2.357 2.358 10.299 12.206 2.361 211.6 
28 -17.316 -17.308 -1.833 -27.959 -17.311 209.569 
29 23.766 23.758 8.522 1.450 23.755 209.289 
30 6.661 6.662 -2.304 -0.439 6.658 206.99 
 
aDFT B3LYP/6-31+G(d) Gibbs free energies in kcal mol-1 relative to the absolute G value for the global minimum 
−840032.1537 kcal mol-1. bIn percent from ∆G values at 298 K and 1 atm. cDFT B3LYP/6-31+G(d) Rotatory 
strength values expressed in R(len). dCalculated with the equation ΣiR(len)i × Pi, where R(len)i is the theoretical 
R(len) value calculated for the n = 1-30 excitation state and Pi is the population for the ith conformer. eAveraged 
excitation state. 
 
Figure S21. Calculated ECD at DFT B3LYP/6-31+G(d) theory Level  for 7aS,8S,11aS enantiomer of 1. 
 
Figure S22. Calculated ECD at DFT B3LYP/6-31+G(d) theory Level  for 7aR,8R,11aR enantiomer of 1. 
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Table S5. Geometry Optimization and 1H NMR Single-Point Calculations at DFT B3LYP/6-311+G(2d,p) 
Level of Theory for R Enantiomer of Minimoidione B (2). 
Conformers 
Gauss 
Energy 
Energy 
(kcal/mol) 
∆G 
Molar Fraction 
(kcal/mol) 
1 -1605.912417 -1007725.47 0.00 0.3679715 
2 -1605.912298 -1007725.40 0.07 0.2979745 
4 -1605.911725 -1007725.04 0.43 0.1758294 
3 -1605.911618 -1007724.97 0.50 0.1582246 
 
Conformer Calculated chemical shift (δ)  
01 02 03 04 δ01 δ02 δ03 δ04 δcalcd* δexp |δexp-δcalcd| 
25.3947 25.5191 25.3794 25.2929 6.20845044 6.09190556 6.22278434 6.30382237 6.19 6.36 0.1641 
25.3519 25.7241 25.6406 25.4295 6.24854787 5.8998501 5.97807757 6.17584785 6.09 6.24 0.1537 
26.3886 26.0781 25.9862 26.389 5.27730935 5.56820311 5.65430017 5.27693461 5.42 5.70 0.2792 
28.7284 28.7656 28.7277 28.7055 3.08525389 3.05040285 3.08590969 3.10670789 3.08 3.19 0.1101 
28.3736 28.6768 28.5449 28.3813 3.41765037 3.13359565 3.25716695 3.41043657 3.31 3.39 0.0875 
25.134 24.7947 24.8138 25.1162 6.45268878 6.77056399 6.75267004 6.46936481 6.60 6.66 0.0659 
26.1652 26.1359 26.0287 26.1343 5.48660296 5.51405284 5.61448379 5.51555181 5.52 5.75 0.2338 
25.3816 25.4171 25.3712 25.3549 6.22072325 6.18746487 6.23046655 6.24573731 6.22 6.45 0.2321 
17.9757 17.9201 18.3085 18.302 13.1589844 13.2110736 12.8471988 12.8532884 13.07 13.30 0.2272 
28.0671 28.1252 28.179 28.0594 3.7047967 3.65036537 3.59996253 3.71201049 3.67 3.79 0.1216 
28.0592 28.1645 28.2656 28.0511 3.71219786 3.61354694 3.5188308 3.7197864 3.65 3.79 0.1414 
27.7667 27.8719 27.9628 27.7495 3.98622822 3.88767098 3.80251077 4.00234214 3.93 3.79 0.1357 
27.8571 27.7599 27.7791 27.851 3.90153644 3.99259884 3.9746112 3.90725126 3.94 3.84 0.1013 
28.2354 28.1669 28.1137 28.2188 3.54712385 3.61129848 3.66113922 3.56267566 3.59 3.84 0.2529 
28.2343 28.2205 27.95 28.2187 3.54815439 3.56108301 3.81450253 3.56276935 3.60 3.84 0.2432 
28.1235 28.3524 28.7544 28.2259 3.65195803 3.43751171 3.06089563 3.55602398 3.48 3.67 0.1949 
28.1085 28.3526 28.5618 28.2609 3.66601087 3.43732434 3.24133408 3.52323403 3.51 3.67 0.1670 
27.8766 28.0052 28.1685 27.9317 3.88326775 3.76278808 3.60979951 3.83164699 3.80 3.67 0.1224 
28.3915 28.0663 28.1732 28.3765 3.40088064 3.70554619 3.60539629 3.41493348 3.53 3.80 0.2770 
28.2079 27.7904 27.7235 28.1835 3.57288739 3.96402473 4.02670039 3.59574667 3.77 3.80 0.0382 
28.4171 28.1349 28.2778 28.3821 3.37689713 3.64127787 3.50740116 3.40968709 3.48 3.80 0.3214 
18.2267 18.1742 18.1985 18.1953 12.9238336 12.9730185 12.950253 12.9532509 12.95 13.14 0.1954 
 
*Computed with B3LYP/6-311+G(2d,p)//B3LYP/6-311+G(2d,p). 
 
 
 
 
 
 
Table S6. Comparison of computed and experimental 1H NMR data for R enantiomer of 2.  
Position δH Exp δH Calcd*  
3 5.70 5.42 
 
6 6.36 6.19 
8 6.24 6.09 
2-OCH3 3.80 3.59 
7-OCH3 3.67 3.59 
1' 
3.19 3.08 
3.39 3.31 
2' 6.66 6.60 
5' 5.75 5.52 
8' 6.45 6.22 
4'-OCH3 3.84 3.71 
9'-OCH3 3.79 3.75 
OH-5 13.30 13.07 
OH-7' 13.14 12.95 
MAE 0.166  
 
*Chemical shifts were derived from application of scaling factors (slope = −1.0674, intercept = 32.0216) to the 1H NMR shielding tensors 
computed at the B3LYP/6-311+G(2d,p) Level  of theory. 
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Table S7. Geometry Optimization and 1H NMR Single-Point Calculations at DFT B3LYP/6-311+G(2d,p) 
Level of Theory for S Enantiomer of Minimoidione B (2). 
Conformer 
Gauss 
Energy 
Energy 
(kcal/mol) 
∆G 
Molar Fraction 
(kcal/mol) 
1 -1605.912417 -1007725.471 0.00 0.5 
3 -1605.912417 -1007725.471 0.00 0.5 
2 -1605.911725 -1007725.037 0.43 0 
 
Conformer Calculated chemical shift (δ)    
01 02 03 δ01 δ02 δ03 δcalcd* δexp |δexp-δcalcd| 
25.3816 25.3549 25.3816 6.22072325 6.24573731 6.22072325 6.22 6.45 0.2282 
26.1652 26.1343 26.1653 5.48660296 5.51555181 5.48650927 5.49 5.75 0.2673 
25.134 25.1162 25.134 6.45268878 6.46936481 6.45268878 6.45 6.66 0.2110 
28.7284 28.7055 28.7284 3.08525389 3.10670789 3.08525389 3.09 3.19 0.1036 
28.3736 28.3813 28.3736 3.41765037 3.41043657 3.41765037 3.42 3.39 0.0239 
25.3519 25.4295 25.3519 6.24854787 6.17584785 6.24854787 6.25 6.24 0.0057 
25.3947 25.293 25.3947 6.20845044 6.30372869 6.20845044 6.21 6.36 0.1484 
26.3886 26.389 26.3886 5.27730935 5.27693461 5.27730935 5.28 5.70 0.4255 
17.9758 18.302 17.9758 13.1588908 12.8532884 13.1588908 13.16 13.30 0.1397 
18.2268 18.1954 18.2266 12.9237399 12.9531572 12.9239273 12.92 13.14 0.2194 
28.0592 28.0511 28.0592 3.71219786 3.7197864 3.71219786 3.71 3.79 0.0827 
28.0671 28.0594 28.0671 3.7047967 3.71201049 3.7047967 3.70 3.79 0.0901 
27.7667 27.7495 27.7667 3.98622822 4.00234214 3.98622822 3.99 3.79 0.1913 
28.2354 28.2188 28.2354 3.54712385 3.56267566 3.54712385 3.55 3.84 0.2928 
27.8571 27.8511 27.8571 3.90153644 3.90715758 3.90153644 3.90 3.84 0.0616 
28.2343 28.2188 28.2343 3.54815439 3.56267566 3.54815439 3.55 3.84 0.2917 
28.3916 28.3765 28.3916 3.40078696 3.41493348 3.40078696 3.40 3.80 0.4027 
28.4171 28.3821 28.4171 3.37689713 3.40968709 3.37689713 3.38 3.80 0.4266 
28.2079 28.1835 28.2079 3.57288739 3.59574667 3.57288739 3.57 3.80 0.2306 
27.8766 27.9316 27.8766 3.88326775 3.83174068 3.88326775 3.88 3.67 0.2107 
28.1085 28.2608 28.1085 3.66601087 3.52332771 3.66601087 3.67 3.67 0.0066 
28.1235 28.2259 28.1235 3.65195803 3.55602398 3.65195803 3.65 3.67 0.0206 
 
*Computed with B3LYP/6-311+G(2d,p)//B3LYP/6-311+G(2d,p). 
 
 
 
 
Table S8. Comparison of computed and experimental 1H NMR data for S enantiomer of 2.  
Position δH Exp δH Calcd*  
3 5.70 5.28 
 
6 6.36 6.21 
8 6.24 6.25 
2-OCH3 3.80 3.45 
7-OCH3 3.67 3.73 
1' 
3.19 3.09 
3.39 3.42 
2' 6.66 6.45 
5' 5.75 5.49 
8' 6.45 6.22 
4'-OCH3 3.84 3.67 
9'-OCH3 3.79 3.80 
OH-5 13.30 13.16 
OH-7' 13.14 12.92 
MAE 0.169  
*Chemical shifts were derived from application of scaling factors (slope = −1.0674, intercept = 32.0216) to the 1H NMR shielding tensors 
computed at the B3LYP/6-311+G(2d,p) Level  of theory. 
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Table S9. Inhibitory Effect and docking binding energies (∆G) of Compounds 1−4 Tested Against Yeast 
α-Glucosidase (αGHY) 
compound IC50 (µM) ∆G (kcal mol
-1
) 
minimoidione A (1) 95.2 ± 0.8 −8.5 
minimoidione B (2) 2.9 ± 0.47 
−7.7 (R) 
−10.3 (S) 
preussochromone C (3) 66.5 ± 0.97 −7.9 
corymbiferone (4) 155.5 ± 4.25 −7.6 
acarbose* 876.9 ± 38.8 −9.9 
*Acarbose was used as positive control for αGHY. 
 
 
Figure S23. 2D Representation of the interactions among αGHY and acarbose in the predicted binding 
site. 
 
 
 
 
 
 
Table S10. Crystal Data and Structure Refinement for Minimoidione A (1). 
 
Identification code  072XYZ16  
Empirical formula  C21 H20 O7  
Formula weight  384.37  
Temperature  150(2) K  
Wavelength  0.71073 Å  
Crystal system  Monoclinic  
Space group  P 21/n  
Unit cell dimensions a = 9.1302(13) Å α= 90°. 
 b = 15.476(2) Å β= 109.085(3)°. 
 c = 13.420(2) Å γ = 90°. 
Volume 1792.0(4) Å3  
Z 4  
Density (calculated) 1.425 Mg/m3  
Absorption coefficient 0.107 mm-1  
F(000) 808  
Crystal size 0.273 x 0.118 x 0.076 mm3  
Theta range for data collection 2.382 to 25.193°.  
Index ranges -10<=h<=10, -18<=k<=18, -16<=l<=15 
Reflections collected 10832  
Independent reflections 3193 [R(int) = 0.1193]  
Completeness to theta = 25.193° 99.0 %   
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3193 / 2 / 263  
Goodness-of-fit on F2 0.970  
Final R indices [I>2sigma(I)] R1 = 0.0568, wR2 = 0.1138  
R indices (all data) R1 = 0.1021, wR2 = 0.1404  
Largest diff. peak and hole 0.354 and -0.426 e.Å-3  
   
 
 
 
 
 
 
Atomic coordinates (× 104) and equivalent isotropic displacement parameters (Å2 × 103) for preussiaminimoidione I 
(1). U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
 
 x y z U(eq) 
O(1) 7495(2) 6098(1) 10434(1) 32(1) 
O(2) 8813(2) 6064(1) 8998(2) 32(1) 
O(3) 5736(2) 3495(1) 11525(1) 31(1) 
O(4) 4343(2) 1091(1) 8919(2) 45(1) 
O(5) 6836(2) 339(1) 10311(2) 47(1) 
O(6) 10245(2) 2321(1) 9545(1) 27(1) 
O(7) 9226(2) 3315(1) 7507(1) 27(1) 
C(1) 7281(3) 5297(2) 10344(2) 24(1) 
C(2) 6659(3) 4834(2) 11052(2) 25(1) 
C(3) 6323(3) 3982(2) 10913(2) 23(1) 
C(4) 6529(3) 3503(2) 10030(2) 22(1) 
C(5) 5844(3) 2736(2) 9712(2) 26(1) 
C(6) 5965(3) 2275(2) 8759(2) 26(1) 
C(7) 7564(3) 2464(2) 8642(2) 22(1) 
C(8) 7888(3) 3430(2) 8720(2) 21(1) 
C(9) 8726(3) 3839(2) 8145(2) 21(1) 
C(10) 9024(3) 4723(2) 8243(2) 23(1) 
C(11) 8505(3) 5204(2) 8928(2) 22(1) 
C(12) 7707(3) 4812(2) 9545(2) 21(1) 
C(13) 7403(3) 3918(2) 9420(2) 20(1) 
C(14) 5825(3) 1295(2) 8870(2) 30(1) 
C(15) 7113(3) 928(2) 9780(2) 31(1) 
C(16) 8634(3) 1272(2) 9969(2) 31(1) 
C(17) 8860(3) 1974(2) 9447(2) 25(1) 
C(18) 5482(3) 3904(2) 12418(2) 36(1) 
C(19) 4662(3) 2584(2) 7775(2) 36(1) 
C(20) 11615(3) 1905(2) 10227(2) 37(1) 
C(21) 10226(3) 3676(2) 6986(2) 36(1) 
 
 
Bond lengths [Å] and angles [°] for minimoidione A (1). 
 
O(1)-C(1) 1.254(3) C(7)-H(7) 1.0000 
O(2)-C(11) 1.358(3) C(8)-C(13) 1.385(3) 
O(2)-H(2A) 0.859(10) C(8)-C(9) 1.403(3) 
O(3)-C(3) 1.349(3) C(9)-C(10) 1.393(3) 
O(3)-C(18) 1.439(3) C(10)-C(11) 1.381(3) 
O(4)-C(14) 1.412(3) C(10)-H(10) 0.9500 
O(4)-H(4) 0.860(10) C(11)-C(12) 1.407(3) 
O(5)-C(15) 1.233(3) C(12)-C(13) 1.409(3) 
O(6)-C(17) 1.340(3) C(14)-C(15) 1.503(4) 
O(6)-C(20) 1.438(3) C(14)-H(14) 1.0000 
O(7)-C(9) 1.361(3) C(15)-C(16) 1.430(4) 
O(7)-C(21) 1.433(3) C(16)-C(17) 1.345(3) 
C(1)-C(2) 1.446(4) C(16)-H(16) 0.9500 
C(1)-C(12) 1.461(3) C(18)-H(18A) 0.9800 
C(2)-C(3) 1.354(3) C(18)-H(18B) 0.9800 
C(2)-H(2) 0.9500 C(18)-H(18C) 0.9800 
C(3)-C(4) 1.461(3) C(19)-H(19A) 0.9800 
C(4)-C(5) 1.343(3) C(19)-H(19B) 0.9800 
C(4)-C(13) 1.466(3) C(19)-H(19C) 0.9800 
C(5)-C(6) 1.501(4) C(20)-H(20A) 0.9800 
C(5)-H(5) 0.9500 C(20)-H(20B) 0.9800 
C(6)-C(14) 1.533(3) C(20)-H(20C) 0.9800 
C(6)-C(19) 1.536(4) C(21)-H(21A) 0.9800 
C(6)-C(7) 1.547(4) C(21)-H(21B) 0.9800 
C(7)-C(17) 1.519(3) C(21)-H(21C) 0.9800 
C(7)-C(8) 1.521(3)   
    
C(11)-O(2)-H(2A) 104(2) C(3)-C(2)-C(1) 120.8(2) 
C(3)-O(3)-C(18) 117.8(2) C(3)-C(2)-H(2) 119.6 
C(14)-O(4)-H(4) 105(2) C(1)-C(2)-H(2) 119.6 
C(17)-O(6)-C(20) 118.6(2) O(3)-C(3)-C(2) 125.3(2) 
C(9)-O(7)-C(21) 118.2(2) O(3)-C(3)-C(4) 113.2(2) 
O(1)-C(1)-C(2) 120.5(2) C(2)-C(3)-C(4) 121.5(2) 
O(1)-C(1)-C(12) 120.5(2) C(5)-C(4)-C(3) 122.3(2) 
C(2)-C(1)-C(12) 118.9(2) C(5)-C(4)-C(13) 119.5(2) 
 
 
 
 
 
C(3)-C(4)-C(13) 117.9(2) O(4)-C(14)-H(14) 107.2 
C(4)-C(5)-C(6) 122.3(2) C(15)-C(14)-H(14) 107.2 
C(4)-C(5)-H(5) 118.9 C(6)-C(14)-H(14) 107.2 
C(6)-C(5)-H(5) 118.9 O(5)-C(15)-C(16) 122.9(3) 
C(5)-C(6)-C(14) 110.9(2) O(5)-C(15)-C(14) 119.7(2) 
C(5)-C(6)-C(19) 109.4(2) C(16)-C(15)-C(14) 117.4(2) 
C(14)-C(6)-C(19) 109.0(2) C(17)-C(16)-C(15) 120.9(3) 
C(5)-C(6)-C(7) 109.3(2) C(17)-C(16)-H(16) 119.6 
C(14)-C(6)-C(7) 108.0(2) C(15)-C(16)-H(16) 119.6 
C(19)-C(6)-C(7) 110.2(2) O(6)-C(17)-C(16) 125.0(2) 
C(17)-C(7)-C(8) 110.69(19) O(6)-C(17)-C(7) 111.1(2) 
C(17)-C(7)-C(6) 112.0(2) C(16)-C(17)-C(7) 123.9(2) 
C(8)-C(7)-C(6) 110.4(2) O(3)-C(18)-H(18A) 109.5 
C(17)-C(7)-H(7) 107.9 O(3)-C(18)-H(18B) 109.5 
C(8)-C(7)-H(7) 107.9 H(18A)-C(18)-H(18B) 109.5 
C(6)-C(7)-H(7) 107.9 O(3)-C(18)-H(18C) 109.5 
C(13)-C(8)-C(9) 118.7(2) H(18A)-C(18)-H(18C) 109.5 
C(13)-C(8)-C(7) 119.0(2) H(18B)-C(18)-H(18C) 109.5 
C(9)-C(8)-C(7) 122.2(2) C(6)-C(19)-H(19A) 109.5 
O(7)-C(9)-C(10) 123.3(2) C(6)-C(19)-H(19B) 109.5 
O(7)-C(9)-C(8) 115.7(2) H(19A)-C(19)-H(19B) 109.5 
C(10)-C(9)-C(8) 121.0(2) C(6)-C(19)-H(19C) 109.5 
C(11)-C(10)-C(9) 119.6(2) H(19A)-C(19)-H(19C) 109.5 
C(11)-C(10)-H(10) 120.2 H(19B)-C(19)-H(19C) 109.5 
C(9)-C(10)-H(10) 120.2 O(6)-C(20)-H(20A) 109.5 
O(2)-C(11)-C(10) 117.7(2) O(6)-C(20)-H(20B) 109.5 
O(2)-C(11)-C(12) 121.2(2) H(20A)-C(20)-H(20B) 109.5 
C(10)-C(11)-C(12) 121.0(2) O(6)-C(20)-H(20C) 109.5 
C(11)-C(12)-C(13) 118.2(2) H(20A)-C(20)-H(20C) 109.5 
C(11)-C(12)-C(1) 121.6(2) H(20B)-C(20)-H(20C) 109.5 
C(13)-C(12)-C(1) 120.2(2) O(7)-C(21)-H(21A) 109.5 
C(8)-C(13)-C(12) 121.5(2) O(7)-C(21)-H(21B) 109.5 
C(8)-C(13)-C(4) 119.5(2) H(21A)-C(21)-H(21B) 109.5 
C(12)-C(13)-C(4) 119.0(2) O(7)-C(21)-H(21C) 109.5 
O(4)-C(14)-C(15) 112.6(2) H(21A)-C(21)-H(21C) 109.5 
O(4)-C(14)-C(6) 109.7(2) H(21B)-C(21)-H(21C) 109.5 
C(15)-C(14)-C(6) 112.6(2)   
Anisotropic displacement parameters (Å2 × 103) for minimoidione A (1). The anisotropic displacement factor exponent 
takes the form: -2π2 [h2 a*2U11 + ...  + 2 h k a* b* U12] 
    
 U11 U22 U33 U23 U13 U12 
O(1) 32(1)  22(1) 41(1)  -3(1) 13(1)  0(1) 
O(2) 38(1)  19(1) 41(1)  2(1) 17(1)  -2(1) 
O(3) 34(1)  35(1) 27(1)  1(1) 16(1)  -5(1) 
O(4) 29(1)  41(1) 59(2)  13(1) 7(1)  -14(1) 
O(5) 40(1)  35(1) 67(2)  22(1) 19(1)  -5(1) 
O(6) 22(1)  25(1) 34(1)  2(1) 7(1)  -1(1) 
O(7) 35(1)  26(1) 25(1)  -3(1) 16(1)  -5(1) 
C(1) 17(1)  23(1) 29(2)  0(1) 3(1)  2(1) 
C(2) 22(1)  29(2) 23(1)  -2(1) 7(1)  2(1) 
C(3) 16(1)  32(2) 22(1)  3(1) 6(1)  2(1) 
C(4) 20(1)  23(1) 24(1)  3(1) 7(1)  0(1) 
C(5) 21(1)  25(1) 31(2)  6(1) 8(1)  -4(1) 
C(6) 24(2)  23(1) 28(2)  -2(1) 5(1)  -7(1) 
C(7) 24(1)  21(1) 19(1)  -1(1) 6(1)  -4(1) 
C(8) 17(1)  21(1) 20(1)  2(1) 1(1)  -1(1) 
C(9) 21(1)  24(1) 16(1)  1(1) 3(1)  -2(1) 
C(10) 24(2)  24(1) 21(1)  4(1) 7(1)  -4(1) 
C(11) 19(1)  17(1) 26(1)  4(1) 3(1)  -2(1) 
C(12) 18(1)  20(1) 23(1)  2(1) 3(1)  0(1) 
C(13) 16(1)  23(1) 18(1)  2(1) 1(1)  0(1) 
C(14) 31(2)  24(2) 35(2)  -5(1) 10(1)  -10(1) 
C(15) 31(2)  20(1) 44(2)  -1(1) 14(2)  -4(1) 
C(16) 28(2)  26(2) 38(2)  7(1) 10(1)  1(1) 
C(17) 25(2)  22(1) 26(2)  -5(1) 8(1)  -4(1) 
C(18) 33(2)  49(2) 26(2)  -2(1) 12(1)  -3(1) 
C(19) 29(2)  37(2) 36(2)  5(1) 3(1)  -8(1) 
C(20) 24(2)  35(2) 49(2)  8(1) 6(1)  2(1) 
C(21) 44(2)  38(2) 33(2)  -6(1) 22(2)  -11(1) 
 
 
 
 
Hydrogen coordinates (× 104) and isotropic displacement parameters (Å2 × 10 3) for minimoidione A (1). 
 
 x y z U(eq) 
H(2A) 8440(30) 6238(18) 9473(17) 38 
H(4) 4500(40) 651(13) 9330(20) 54 
H(2) 6485 5132 11622 30 
H(5) 5264 2478 10105 31 
H(7) 7530 2270 7924 26 
H(10) 9580 4993 7842 28 
H(14) 5905 1025 8213 36 
H(16) 9497 1000 10470 37 
H(18A) 6460 4147 12880 53 
H(18B) 5097 3475 12810 53 
H(18C) 4717 4367 12173 53 
H(19A) 3661 2516 7887 54 
H(19B) 4671 2240 7164 54 
H(19C) 4824 3195 7646 54 
H(20A) 11585 1901 10950 56 
H(20B) 12534 2221 10206 56 
H(20C) 11658 1310 9989 56 
H(21A) 9661 4115 6480 54 
H(21B) 10576 3217 6613 54 
H(21C) 11126 3942 7509 54 
Hydrogen bonds for minimoidione A (1) [Å and °]. 
 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
O(2)-H(2A)...O(1) 0.859(10) 1.784(16) 2.585(3) 154(3) 
O(4)-H(4)...O(5) 0.860(10) 2.17(3) 2.692(3) 119(3) 
O(4)-H(4)...O(5)#1 0.860(10) 2.11(2) 2.802(3) 138(3) 
Symmetry transformations used to generate equivalent atoms: 
#1 -x+1,-y,-z+2 
 
 
